Avenue Therapeutics, Inc. acquired Baergic Bio, Inc from Fortress Biotech, Inc.
Avenue Therapeutics, Inc. (NasdaqCM:ATXI) completed the acquisition of majority stake of Baergic Bio, Inc. from Fortress Biotech, Inc. (NasdaqCM:FBIO) on November 7, 2022.